← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Quench Medical, Inc.
Saint Paul, MN
$5,631,185
Total funding
7
Grants
Funding over time
peak $1.6M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,631,185 · 7
By mechanism
R44$4,051,771 · 2
R43$1,329,599 · 4
SB1$249,815 · 1
Investigators at Quench Medical, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Treating severe asthma in the small airways with a highly efficient and penetrating inhaled dry powder$1,247,479
R44 · FY2020 · HL
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation$1,127,538
R44 · FY2023 · CA
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation$874,452
R44 · FY2024 · CA
Treating severe asthma in the small airways with a highly efficient and penetrating inhaled dry powder$802,302
R44 · FY2021 · HL
A novel inhaled dry powder psychoplastogenic formulation for treating persons with opioid use disorder$404,917
R43 · FY2024 · DA
Treating non-small cell lung tumors with a novel inhaled dry powder chemotherapeutic formulation$400,000
R43 · FY2020 · CA
Stop pulmonary airleaks with a novel inhaled dry powder aerosol$299,838
R43 · FY2023 · HL
Preparing IND filing for novel lung cancer therapeutic$249,815
SB1 · FY2025 · CA
Treating severe asthma in the small airways: a novel inhaled dry powder formulation$224,844
R43 · FY2018 · HL